一名成年多菌型麻风患者发生厚皮马拉色菌菌血症。
Malassezia pachydermatis fungemia in an adult with multibacillary leprosy.
作者信息
Roman Jorge, Bagla Prabhava, Ren Ping, Blanton Lucas S, Berman Megan A
机构信息
School of Medicine, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.
Department of Infectious Diseases, The University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA.
出版信息
Med Mycol Case Rep. 2016 Jun 2;12:1-3. doi: 10.1016/j.mmcr.2016.05.002. eCollection 2016 Jun.
Abstract
Malassezia pachydermatis is a relatively rare agent of bloodstream infections. We describe an unusual case of Malassezia fungemia in an adult patient hospitalized for Staphylococcus aureus bacteremia who was also found to have multibacillary leprosy. Treatment of the patient required extensive medical management but resulted in a good outcome.
摘要
厚皮马拉色菌是一种相对罕见的血流感染病原体。我们描述了一例不寻常的成人马拉色菌血症病例，该患者因金黄色葡萄球菌菌血症住院，同时还被诊断为多菌型麻风。对该患者的治疗需要广泛的医疗管理，但最终取得了良好的效果。
相似文献
1
Malassezia pachydermatis fungemia in an adult with multibacillary leprosy.
Med Mycol Case Rep. 2016 Jun 2;12:1-3. doi: 10.1016/j.mmcr.2016.05.002. eCollection 2016 Jun.
2
Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Med Mycol. 2015 Sep;53(7):743-8. doi: 10.1093/mmy/myv049. Epub 2015 Jul 10.
3
Clinical and microbiological features of infection with Malassezia pachydermatis in high-risk infants.
J Infect Dis. 1988 Jun;157(6):1163-8. doi: 10.1093/infdis/157.6.1163.
4
Malassezia pachydermatis fungemia in a preterm neonate resistant to fluconazole and flucytosine.
Med Mycol Case Rep. 2014 May 10;5:9-11. doi: 10.1016/j.mmcr.2014.04.004. eCollection 2014 Jul.
5
A review of the biology of canine skin with respect to the commensals Staphylococcus intermedins, Demodex canis and Malassezia pachydermatis.
Vet Dermatol. 1996 Sep;7(3):119-132. doi: 10.1111/j.1365-3164.1996.tb00237.x.
6
Standardization of Galleria mellonella as an Infection Model for Malassezia furfur and Malassezia pachydermatis.
Methods Mol Biol. 2023;2667:15-29. doi: 10.1007/978-1-0716-3199-7_2.
7
Systemic Infection Caused by Malassezia pachydermatis in Infants: Case Series and Review of the Literature.
Pediatr Infect Dis J. 2020 May;39(5):444-448. doi: 10.1097/INF.0000000000002591.
8
Blood culture procedures and diagnosis of Malassezia furfur bloodstream infections: Strength and weakness.
Med Mycol. 2018 Oct 1;56(7):828-833. doi: 10.1093/mmy/myx122.
9
Malassezia pachydermatis carriage in dog owners.
Emerg Infect Dis. 2005 Jan;11(1):83-8. doi: 10.3201/eid1101.040882.
10
Invasive Infection in an 8-Year-Old Child on Lipid Parenteral Nutrition.
Case Rep Infect Dis. 2022 Jan 20;2022:8636582. doi: 10.1155/2022/8636582. eCollection 2022.
引用本文的文献
1
The Zoonotic Potential of Fungal Pathogens: Another Dimension of the One Health Approach.
Diagnostics (Basel). 2024 Sep 15;14(18):2050. doi: 10.3390/diagnostics14182050.
2
bloodstream infection: still a diagnostic challenge in clinical practice.
Med Mycol Case Rep. 2024 Jul 3;45:100657. doi: 10.1016/j.mmcr.2024.100657. eCollection 2024 Sep.
3
from brown bear: A comprehensive analysis reveals novel genotypes and distribution of all detected variants in domestic and wild animals.
Front Microbiol. 2023 Apr 12;14:1151107. doi: 10.3389/fmicb.2023.1151107. eCollection 2023.
4
: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.
J Fungi (Basel). 2022 Jul 4;8(7):708. doi: 10.3390/jof8070708.
5
Molecular identification of species isolated from neonates hospitalized in Neonatal intensive care units and their mothers.
Curr Med Mycol. 2021 Sep;7(3):13-17. doi: 10.18502/cmm.7.3.7800.
6
in Inflammatory Bowel Disease: Accomplice of Evoking Tumorigenesis.
Front Immunol. 2022 Mar 4;13:846469. doi: 10.3389/fimmu.2022.846469. eCollection 2022.
7
Investigation of Alternative Therapeutic and Biocidal Options to Combat Antifungal-Resistant Zoonotic Fungal Pathogens Isolated from Companion Animals.
Infect Dis Rep. 2021 Apr 11;13(2):348-366. doi: 10.3390/idr13020034.
8
In Vitro or In Vivo Models, the Next Frontier for Unraveling Interactions between spp. and Hosts. How Much Do We Know?
J Fungi (Basel). 2020 Aug 28;6(3):155. doi: 10.3390/jof6030155.
9
spp. Yeasts of Emerging Concern in Fungemia.
Front Cell Infect Microbiol. 2020 Jul 28;10:370. doi: 10.3389/fcimb.2020.00370. eCollection 2020.
10
as a Novelty Model of Host-Pathogen Interaction for CBS 1878 and CBS 1879.
Front Cell Infect Microbiol. 2020 May 5;10:199. doi: 10.3389/fcimb.2020.00199. eCollection 2020.
本文引用的文献
1
Malassezia species in healthy skin and in dermatological conditions.
Int J Dermatol. 2016 May;55(5):494-504. doi: 10.1111/ijd.13116. Epub 2015 Dec 29.
2
Leprous lesion presents enrichment of opportunistic pathogenic bacteria.
Springerplus. 2015 Apr 18;4:187. doi: 10.1186/s40064-015-0955-1. eCollection 2015.
3
Malassezia pachydermatis fungaemia in an adult on posaconazole prophylaxis for acute myeloid leukaemia.
Pathology. 2014 Aug;46(5):466-7. doi: 10.1097/PAT.0000000000000139.
4
Malassezia yeasts: how many species infect humans and animals?
PLoS Pathog. 2014 Feb 27;10(2):e1003892. doi: 10.1371/journal.ppat.1003892. eCollection 2014 Feb.
5
The human microbiome: at the interface of health and disease.
Nat Rev Genet. 2012 Mar 13;13(4):260-70. doi: 10.1038/nrg3182.
6
Comparative evaluation of three commercial identification systems using common and rare bloodstream yeast isolates.
J Clin Microbiol. 2011 Jul;49(7):2722-7. doi: 10.1128/JCM.01253-10. Epub 2011 May 4.
7
Minireview: Malassezia infections in immunocompromised patients.
Mycoses. 2010 May;53(3):187-95. doi: 10.1111/j.1439-0507.2009.01814.x. Epub 2009 Dec 17.
8
Antifungal activities of azole agents against the Malassezia species.
Int J Antimicrob Agents. 2007 Mar;29(3):281-4. doi: 10.1016/j.ijantimicag.2006.09.016. Epub 2007 Jan 16.
9
Malassezia pachydermatis carriage in dog owners.
Emerg Infect Dis. 2005 Jan;11(1):83-8. doi: 10.3201/eid1101.040882.
10
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Antimicrob Agents Chemother. 2003 Jul;47(7):2342-4. doi: 10.1128/AAC.47.7.2342-2344.2003.
Zotero 插件